Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Compare index fund performance year by year to detect stability, volatility, and opportunities for strategic adjustments.
25,004 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Investors eye Xcel Brands (XELB) 2026 as it reports Q1 results. This guide explains what to look for in the transcrip...
EWZ’s semi-annual payouts are highly dependent on Petrobras and Vale, delivering big checks in buoyant commodity mark...
A trio of monthly-paying funds could steady-cash a $100,000 portfolio to about $750 a month, aiming for $9,000 in ann...
As market conditions shift, three S&P 500 covered call ETFs stand out for high monthly distributions without eroding ...
A legendary friendship reveals powerful money lessons. Learn how trust, communication, and smart risk-taking can stre...
The U.S. Department of Justice launches a nearly $1.8 billion fund to address claims of political targeting, promptin...
A Los Angeles jury ordered Meta and Google to pay $6 million after a 20-year-old woman claimed childhood exposure to ...
Starting with a cash purchase, a young investor builds momentum, cuts debt service, and scales toward sizable monthly...
A high-yield ETF promises sky-high payouts but posted negative returns over the last year as investors weigh the true...
BNO has jumped about 52% year-to-date, yet roll costs and futures contango are quietly eroding its gains. Here's what...
We dive into the outrageous spending patterns that define the ultra-wealthy and uncover practical, down-to-earth step...